Late medical sequelae after therapy for supradiaphragmatic Hodgkin's disease

Citation
Af. Abrahamsen et al., Late medical sequelae after therapy for supradiaphragmatic Hodgkin's disease, ACTA ONCOL, 38(4), 1999, pp. 511-515
Citations number
29
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ACTA ONCOLOGICA
ISSN journal
0284186X → ACNP
Volume
38
Issue
4
Year of publication
1999
Pages
511 - 515
Database
ISI
SICI code
0284-186X(1999)38:4<511:LMSATF>2.0.ZU;2-Y
Abstract
A total of 221 consecutive early stage Hodgkin's disease (HD) patients were given mantle held irradiation only or in combination with chemotherapy in 1971-1991. in 1991 these patients responded to a mailed self-report questio nnaire covering items on late medical symptoms. Of 200 patients (91%) who r eported that their thyroid function had been tested, 110 patients (55% of t hose rested) had thyroid hypofunction at follow-up in 1994. Ninety-five pat ients (86% of patients with biochemical hypothyreosis) had started hormonal substitution. In 1993 and 1994. 101 of these patients who had received man tle field irradiation in 1980-1988 were called in for interview. clinical e xamination and thyroid function tests. Eighteen patients (18%) had started hormonal substitution treatment earlier, but 58 (70%) of the other 83 patie nts were found to have biochemical hypothyreosis. Of the 221 patients who c ompleted the questionnaire, 66 patients (30%) reported dyspnoea on exertion for more than 3 years after treatment, 8 patients (4%) reported a history of myocardial infarction, 6 patients (3%) reported pericardial disease and 25 patients (11%) heart valve disease. Increased expenses incurred for dent al care were reported by 106 patients (48%), increasing to 55% when Waldrye r's ring had been irradiated. The consequences of late sequelae after mantl e field irradiation for future treatment are discussed.